FBIO(FBIO)
FBIO
Q3 2026 EPS Estimate
$-0.20
Aug 13, 2026 · Reports before open
Revenue Estimate
$18M
FY2026E EPS$2.40
Analyst Sentiment
Wall St. Consensus
Buy6 analysts·Limited coverage
75
Score
6 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
6100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$5.00
+63.1%
Consensus
$5.00
+63.1%
Bull
$5.00
+63.1%
12-Month Target Range6 analysts
$5.00$5.00$5.00
Current $3.06Consensus
Current Price
$3.06
Upside to Consensus
$1.94
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+53.99%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $80M | $123M |
| Low | $78M | $120M |
| High | $82M | $126M |
| EBITDA Avg | $-69M | $-106M |
| Low | $-71M | $-109M |
| High | $-67M | $-104M |
| EBIT Avg | $-70M | $-108M |
| Low | $-72M | $-111M |
| High | $-69M | $-105M |
| Net Income Avg | $670M | $-140M |
| Low | $649M | $-144M |
| High | $690M | $-135M |
| EPS Avg | $2.40 | $-0.50 |
| Low | $2.33 | $-0.52 |
| High | $2.47 | $-0.48 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $22M | $23M |
| Low | $22M | $23M |
| High | $22M | $23M |
| EBITDA Avg | $-19M | $-20M |
| Low | $-19M | $-20M |
| High | $-19M | $-20M |
| EBIT Avg | $-20M | $-20M |
| Low | $-20M | $-20M |
| High | $-20M | $-20M |
| Net Income Avg | $-6M | $-5M |
| Low | $-6M | $-5M |
| High | $-6M | $-5M |
| EPS Avg | $-0.15 | $-0.14 |
| Low | $-0.15 | $-0.14 |
| High | $-0.15 | $-0.14 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |